ALMR
Alamar Biosciences, Inc. NASDAQ Listed Apr 17, 2026$32.13
-3.11%
vs $33.16
Mkt Cap $2.1B
52w Low $19.09
74.6% of range
52w High $36.57
50d MA $25.72
200d MA $24.45
P/E (TTM)
—
EV/EBITDA
—
P/B
—
Debt/Equity
—
ROE
—
P/FCF
—
RSI (14)
69.60
ATR (14)
$2.63
Beta
0.00
50d MA
$25.72
200d MA
$24.45
Avg Volume
279.8K
Alamar Biosciences is a commercial-stage proteomics company focused on ultra-sensitive, multiplexed protein detection for research and future clinical applications. Its platform combines proprietary instruments, consumables, and software to provide an end-to-end system for measuring multiple low-abundance proteins across research and potential clinical applications.
47071 Bayside Parkway · Fremont, CA 94538 · US
Data updated apr 24, 2026 5:24pm
· Source: financialmodelingprep.com